CConflicts Read More Iran-Israel conflict disrupts trial initiations24.07.2025 Escalating conflict between Israel, Iran and the US had a marked impact on clinical trial initiations in Q2…
AAI Read More AI Impact Awards 2025: Every Cure Aims to ‘Teach Old Drugs New Tricks’18.06.2025 Every Cure, a nonprofit working to reveal the untapped potential of existing medications, has emerged as the overall…
UUnited States Read More Tempest Reports Year End 2024 Financial Results and Provides Business Update27.03.2025 Tempest Therapeutics • Granted Both Orphan Drug & Fast Track designations for Amezalpat (TPST-1120) for the treatment of…
UUnited States Read More CytoMed Therapeutics signs Business & Research06.01.2025 SINGAPORE, Jan. 06, 2025 (GLOBE NEWSWIRE) — CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical…